Clinical studies have shown that patients with severe depression have a low level of BDNF in the hippocampus and prefrontal cortex, accompanied by cerebral hippocampus atrophy, neuronal apoptosis and synaptic loss (Duman and Monteggia, 2006). This evidence concerns the gene BDNF and depressive symptom measurement.